Jmas.Jk

JMAS.JK maintains a strong liquidity position, with cash and equivalents amounting to IDR 8.75 billion, representing 7.15% of total assets. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The price-to-book ratio of 2.17 suggests that the company is trading at a premium to its book value, while the price-to-tangible-book ratio is identical, indicating no intangible asset discount.

Profitability metrics for JMAS.JK show a return on equity (ROE) of 2.31% and a return on assets (ROA) of 0.92%, both below the industry median for Life & Health Insurance firms. The company reported a net income of IDR 2.83 billion despite an operating loss of IDR 792 million, indicating that non-operating income or gains significantly contributed to profitability.

Geographically, JMAS.JK operates primarily in Indonesia, with no disclosed segmental breakdown in the latest financials. The company's revenue concentration in a single country exposes it to local economic and regulatory risks, particularly in the insurance sector.

Looking ahead, JMAS.JK is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. The company's free cash flow of IDR 3.55 billion provides flexibility for reinvestment or shareholder returns, though capital expenditures remain modest at IDR 599 million.

Risk factors for JMAS.JK include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's conservative capital structure and lack of long-term debt reduce financial risk, but its reliance on non-operating income raises concerns about the sustainability of current profitability.

Recent filings and transcripts do not indicate any material events or strategic shifts for JMAS.JK. The company's financial performance and risk profile remain stable, with no significant changes in its business operations or capital structure.